Share on

Middle East And Africa Pen Needles Market Research Report – Segmented By Therapy, Type, Needle Length, Mode Of Purchase & By Country(KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Analysis on Size, Share, Trends, Growth, Forecast (2022 to 2027)

Published: March, 2023
ID: 154
Pages: 145
Formats: report pdf report excel report power bi report ppt

MEA Pen Needles Market Size (2022 to 2027)

The Middle East & Africa pen needles market size is expected to reach USD 0.48 billion by 2027 from USD 0.29 billion in 2022, growing at a CAGR of 10.77% for the next five years, 2022 to 2027.

Pen needles are used to deliver the medication (such as insulin or other injectable medications) combined with injection pens. A pen needle comprises a hollow needle attached to an injection pen. Pen needles are available with varied needle lengths and are majorly utilized by diabetes patients.

Growing annual health care expenditure, increasing public & private organizations' involvement in diabetes awareness programs, and rising demand for advanced insulin delivery devices drive the growth of the Middle East & Africa pen needles market. However, limited accessibility of pen needles and lack of health care infrastructure & outdated facilities are restraining the growth of the Middle East & Africa pen needles market.

This research report on the Middle East and Africa Pen Needles Market has been segmented and sub-segmented into the following categories:

By Therapy: 

  • Insulin Therapy
  • GLP-1 Therapy
  • Growth Hormone Therapy

By Type: 

  • Standard Needle
  • Safety Needle

By Needle Length: 

  • 4mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

By Mode of Purchase: 

  • Retail
  • Non-Retail

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Companies leading the MEA Pen Needles Market profiled in this report are Becton Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan) and others.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample